Effect of the rigidification of propranolol, a mixed β-adrenoceptor and 5-HT1AR antagonist

Pharmazie. 2019 Mar 1;74(3):131-135. doi: 10.1691/ph.2019.8878.

Abstract

Propranolol is a popular β adrenergic antagonists that, together with pindolol, binds also to serotoninergic receptors, namely 5-HT1A/B. In this work the rigidification of the propranolol structure by locking its hydroxyl group within a 1,3-dioxolane ring was investigated. Constrained derivatives of propranolol were synthesized, fully characterized and tested for their affinity at β-adrenoreceptors and 5-HT1A/B/C receptors using radioligand binding assay. The constrained derivatives were inactive, as expected, at β1/2/3 adrenergic receptors. Although less expected, these derivatives failed to bind also to 5-HT1A/B/C receptors. The rigidification of propranolol is detrimental for 5-HT1AR activity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenergic beta-Antagonists / chemical synthesis
  • Adrenergic beta-Antagonists / chemistry*
  • Adrenergic beta-Antagonists / pharmacology*
  • Cell Line
  • Dioxolanes / chemistry
  • Humans
  • Propranolol / analogs & derivatives*
  • Propranolol / chemical synthesis
  • Propranolol / chemistry
  • Propranolol / pharmacology*
  • Serotonin 5-HT1 Receptor Antagonists / chemical synthesis
  • Serotonin 5-HT1 Receptor Antagonists / chemistry*
  • Serotonin 5-HT1 Receptor Antagonists / pharmacology*
  • Structure-Activity Relationship

Substances

  • Adrenergic beta-Antagonists
  • Dioxolanes
  • Serotonin 5-HT1 Receptor Antagonists
  • Propranolol
  • formal glycol